Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Cancer Subjects × Tamoxifen × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Carcinoma, Intraductal, Noninfiltrating 3 Ovarian Neoplasms 2 Breast Cancer Female 2 Prostatic Neoplasms 1 Premenopausal Breast Cancer 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Subjects 1

Interventions

Tamoxifen 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06449027 2025-10-01

Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Active not recruiting

Breast Cancer Subjects

Data powered by HemOnc (CC BY 4.0) Colophon ⚡